Free Trial

Activision Surges 10% As Judge OK's Microsoft Acquisition Deal

Activision stock Microsoft

Key Points

  • Activision Blizzard posted its best price action in over a year, reaching $90.99, approaching Microsoft's offer of $95 a share.
  • The FTC can continue to pursue an antitrust lawsuit even if the deal closes.
  • Microsoft has until July 18 to close the deal or it owes Activision $3 billion and must renegotiate the terms.
  • The FTC has been scrutinizing deals in various industries, including pharmaceuticals.
  • 5 stocks we like better than Activision Blizzard.

Activision Blizzard Inc. NASDAQ: ATVI shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. NASDAQ: MSFT to proceed with its acquisition of the game maker. 

It was the stock’s best price action in over a year, with Activision stock finishing at $90.99, approaching Microsoft’s acquisition price of $95, for a total value of $69 billion. 

District Judge Jacqueline Scott Corley nixed the Federal Trade Commission’s motion to get a preliminary injunction to squash the transaction. Many analysts believe the FTC has been more aggressive lately, with concerns about mergers and acquisitions reducing competition in various industries, 

In her comments, Corley wrote, "The Court finds the FTC has not shown a likelihood it will prevail on its claim this particular vertical merger in this specific industry may substantially lessen competition. To the contrary, the record evidence points to more consumer access to 'Call of Duty' and other Activision content."

The acquisition was also challenged by U.K. regulators, but after the U.S. decision, they hit the pause button and agreed to negotiate with Microsoft. 

Activision owns several popular properties, including “Call of Duty,” “Warcraft” and “Candy Crush.” Meanwhile, Microsoft publishes the “Halo” and “Minecraft” series, among others. 

FTC Can Appeal Ruling

Despite the big price move in Activision, reflecting investor confidence that the deal will be completed, the FTC can still appeal the ruling. 

It seems like that’s the next step. In a statement, FTC spokesperson Douglas Farrar said, "We are disappointed in this outcome given the clear threat this merger poses to open competition in cloud gaming, subscription services, and consoles. In the coming days we'll be announcing our next step to continue our fight to preserve competition and protect consumers.”

The FTC can also continue to pursue an antitrust lawsuit even if the deal closes. 

The clock is ticking fast for the companies to complete the transaction. Assuming an appeals court OK’s the deal, or the FTC opts not to appeal, Microsoft has a July 18 deadline to close the deal. Otherwise, under the terms of the deal, it would owe Activision $3 billion and would have to renegotiate. 

FTC's Heavy Hand 

The FTC has been cracking down on deals from several industries. For example, Amgen Inc. NASDAQ: AMGN in December said it would acquire Horizon Therapeutics Public Limited Company NASDAQ: HZNP for $27.8 billion, initially expecting the deal to be completed in the first half of this year.

However, the FTC filed a lawsuit to block the deal, saying it would stifle competition in the pharmaceutical industry

Regulators indicated that Amgen could employ the tactic of "cross-market bundling" by providing rebates on its current drugs, with the aim of influencing insurers and pharmacy benefit managers to Horizon’s products.

Investors Lost Confidence?

Both Activision and Horizon were trading in ways that indicated investors had lost conviction about the deals’ success. 

A look at the Activision Blizzard chart tells the story: The stock bolted 5.91% higher in March when the Microsoft deal was announced. When the FTC began making noises about preventing it from going through, shares fell 11.45%, but have gradually been rising as analysts saw hopeful signs.

Typically, when a company is being acquired, its stock trades sideways, in an extremely narrow range, just below the acquisition price. If a deal looks likely to go through, there’s no more upside in the stock beyond what the acquiring company is willing to pay. That means it’s out of play for individual investors. 

But Activision, after being pushed down by doubts, had room to run. Hence the big gain on July 11.

Microsoft Shares Up Slightly

Microsoft shares were up 0.19% on July 11, recovering from a bout of selling after the Nasdaq 100 announced it would rebalance later this month, resulting in Microsoft having a smaller index weighting. 

Similar to Activision Blizzard, the Horizon Therapeutics chart shows a stock that gapped down hard once the FTC cast doubts upon its acquisition. Horizon shares rose 0.36% in heavy volume on July 11, perhaps indicating some renewed confidence that the FTC won’t win its fight after all.  

Should you invest $1,000 in Activision Blizzard right now?

Before you consider Activision Blizzard, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Activision Blizzard wasn't on the list.

While Activision Blizzard currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Activision Blizzard (ATVI)
1.0525 of 5 stars
$94.42flat1.05%34.59N/AN/A
Amgen (AMGN)
4.4625 of 5 stars
$263.38+0.8%3.61%33.72Hold$319.67
Horizon Therapeutics Public (HZNP)
1.6963 of 5 stars
$116.30flatN/A62.19N/AN/A
Microsoft (MSFT)
4.8621 of 5 stars
$436.60-0.1%0.76%36.02Moderate Buy$508.46
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines